Skip to main content
. 2016 Oct;8(10):2885–2894. doi: 10.21037/jtd.2016.10.75

Figure 2.

Figure 2

Trends in cholesterol level, total lymphocyte count and visceral fat area between diagnosis and the end of follow-up in patients with PNTM disease. (A) Stable patients: patients with sputum conversion or without radiographic deterioration after follow-up for >1 year; (B) progressed patients: patients with continued positive sputum and radiographic deterioration after follow-up for >1 year. T1, diagnosis; T2, follow-up time. PNTM, pulmonary nontuberculous mycobacterial.